A drop in retail sales and producer prices sent the markets down to a lower open with the Dow plunging 118 points to 16,196. Nasdaq dropped 23 points to 4,203.
On the upside
A peer reviewed manuscript detailing the preclinical research for Peregrine Pharmaceuticals' (Nasdaq: PPHM) bavituximab in treating Ebola will be published in the Journal of Immunology Research.
Shares of Dominion Midstream Partners (NYSE: DM) soared on its first trading day.
A second healthcare worker who cared for Thomas E. Duncan has tested positive for Ebola. Shares of Lakeland Industries (Nasdaq: LAKE) surged.
On the downside
AbbVie (NYSE: ABBV) was reevaluating it plan to purchase Shire (Nasdaq: SHPG).
Bank of America (NYSE: BAC) reported a loss of a penny per share for the third quarter.
KeyCorp (NYSE: KEY) disappointed with lower third quarter earnings and revenue that fell short of analyst expectations.
In the broad market, declining issues outpaced advancers by a margin of more than 2 to 1 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 tumbled 15 points to 1862. Bitcoin lost $10 to $392.
Lower open over disappointing data
October 15, 2014 at 10:43 AM EDT